Soluble HLA-G molecules induce apoptosis in natural killer cells

American Journal of Reproductive Immunology

Volumn 56, Issue 1, 2006, Pages 68-76

  Lindaman, Amy ^a   Dowden, Amy ^a   Zavazava, Nicholas ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Immunology Graduate Program   (United States)

Author keywords

Apoptosis; HLA G; ILT 2; Natural killer cells; NK cells

Indexed keywords

HLA G ANTIGEN;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN VITRO STUDY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NICK END LABELING; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; REGULATORY MECHANISM; TARGET CELL;

ANTIBODIES; ANTIGENS, CD; APOPTOSIS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-B7 ANTIGEN; HUMANS; IN SITU NICK-END LABELING; K562 CELLS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS;

EID: 33745050143     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00395.x     Document Type: Article

References (43)

1. Ober C: HLA aTd pregnancy: the paradox of the fetal allograft. Am J Hum Genet 1998; 62:1-5.
2. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Mericucci A, Baricordi OR: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311-315.
3. Hunt JS, Petroff MG, Morales P, Sedlmayr P, Geraghty DE, Ober C: HLA-G in reproduction: Studies on the maternal-fetal interface. Hum Immunol 2000; 61:1113-1117.
4. Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H: Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999; 53:14-22.
5. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, Hunt JS: Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003; 171:6215-6224.
6. Zavazava N, Westphal E, Muller-Ruchholtz W: Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals. J Immunogenet 1990; 17:387-394.
7. Zavazava N, Kronke M: Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996; 2:1005-1010.
8. Krangel MS: Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B-lymphoblastoid cell line. EMBO J 1985; 4:1205-1210.
9. Krangel MS: Secretion of HLA-A and HLA-B antigens via an alternative RNA splicing pathway. J Exp Med 1986; 163:1173-1190.
10. Zavazava N, Bottcher H, Muller-Ruchholtz M: Soluble MHC class-I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42:20-26.
11. Carosella ED, Moreau P, Le Maoult J, Le'Discorde M, Dausset J, Rouas-FreisF N: HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81:199-252.
12. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED: Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001; 98:12150-12155.
13. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311-315.
14. CArosella ED, Moreau P, Aractingi S, Rouas-Freiss N: HLA-G: a shield against inflammatory aggression. Trends Immunol 2001; 22:553-555.
15. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS: HLA-G1 protein expression is not essential for fetal survival. Placenta 1998; 19:127-132.
16. Casro MJ, Morales P, Rojo-Amigo R, Martinez-Laso J, Allende L, Varela P, Garcia-Berciano M, Guillen-Perales J, rnaiz-Villena A: Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. Tissue Antigens 2000; 56:232-239.
17. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, Choppin J, Dausset J, Carosella ED, Kirszenbaum M, Guillet J: A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001; 33:2355-2359.
18. Zavazava N: Soluble HLA cBass I molecules: biological significance and clinical implications. Mol Med Today 1998; 4:116-121.
19. Le Bouteiller P: The role of HLA-G expression in the embryo during implantation. J Gynecol Obstet Biol Reprod (Paris) 2004; 33:S9-S12.
20. Shiroishi M, Kohda D, Maenaka K: Preparation and crystallization of the disulfide-linked HLA-G dimer. Biochem Biophys Acta 2005 [Epub ahead of print].
21. 2 -microglobulin-free HLA-G molecules. J Immunol 2005; 175:4866-4874.
22. Urosevic M, Trojan A, Dummer R: HLA-G and its KIR ligands in cancer-another enigma yet to be solved? J Pathol 2002; 196:252-253.
23. Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R, Trojan A: Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001; 159:817-824.
24. Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R: HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002; 99:609-617.
25. Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U: Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001; 92:369-376.
26. Le Rond S, Le Maoult J, Crepat C, Menier C, Deschamps M, Le Friec G, Amiot L, Durrbach A, Dausset J, Carosella ED, Ronas Friers N: Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients. Eur J Immunol 2004; 34:649-660.
27. Zavazava N: Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42:20-26.
28. Hausmann R, Zavazava N, Steinmann J, Muller-Ruchholtz W: Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin Exp Immunol 1993; 91:183-188.
29. Hansen B, Janssen E, Machleid T, Kronke M, Zavazava N: Purified truncated recombinant HLA-B7 molecules abrogate cell function in alloreactive cytotoxic T lymphocytes by apoptosis induction. Transplantation 1998; 66:818-1822.
30. Contini P, Ghio M, Poggi A, Filaci G, Indineri F, Ferrone J, Pappo F: Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33:125-134.
31. Zavazava N, Westphal E, Olofsson L, Treumer J, Eckstein V, Muller-Rucholtz W: Expression of soluble class I molecules in healthy persons and renal graft patients. Transplant Proc 1993; 22:1876-1877.
32. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL: HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000; 101:191-200.
33. Hausmann R, Zavazava N, Muller-Ruchholtz W: Interaction of purified HLA class-I molecules with alloreactive CTL. Transplant Proc 1991; 23:2255-2257.
34. Behrens D, Lange K, Fried A, Yoo-Ott KA, Richter K, Fandrich F, Kronke M, Zavazava N: Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model. Transplantation 2001; 72:1974-1982.
35. Casares S, Hurtado A, McEvoy RC, Sarukhan A, von Boehmer H, Brumeanu TDL: Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol 2002; 3:383-391.
36. Ulbrecht M, Maier S, Hotmeister V, Falk CS, Brooks AG, McMaster MT, Weiss EH: Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Hum Immunol 2004; 65:200-208.
37. Krangel MS: Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 1986; 163:1173-1190.
38. Freese A, Zavazava N: HLA-B7 beta-pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses. Blood 2002; 99:3286-3292.
39. Murphy B, Magee CC, Alexander SI, Waaga AM, Snoeck HW, Vella JP, Carpenter CB, Satega MH: Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. J Clin Invest 1999; 103:859-867.
40. Zavazava N, Hausmann R, Muller-Ruchholtz W: Inhibition of Anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA. Transplantation 1991; 51:838-842.
41. Lanier LL: On guard-activating NK cell receptors. Nat Immunol 2001; 2:23-27.
42. Lanier LL: Natural killer cell receptor signaling. Curr Opin Immunol 2003; 15:308-314.
43. Riteau B, Menier C, Khalil-Daher I, Martinozzi S, Pla M, Dausset J, Carosella ED, Rouas-Freiss N: HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001; 13:193-201.